DAWN
Day One Biopharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website dayonebio.com
- Employees(FY) 133
- ISIN US23954D1090
Performance
-0.16%
1W
-5.4%
1M
-10.68%
3M
-4.48%
6M
-12.4%
YTD
-7.65%
1Y
Profile
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Technical Analysis of DAWN 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-17 08:30
- 2024-12-16 19:30
- 2024-12-16 09:49
How Trump Can Help Crypto on Day One(CoinDesk)
- 2024-12-06 20:53
- 2024-11-27 10:18
- 2024-11-20 16:30
- 2024-11-20 03:30
- 2024-11-18 08:30
- 2024-11-17 19:30
- 2024-11-12 17:04
- 2024-11-06 09:55
- 2024-11-06 09:02
Exploring Three High Growth Tech Stocks in the United States(Simply Wall St.)
- 2024-11-04 05:51
- 2024-11-01 09:55
- 2024-10-30 17:20
- 2024-10-30 16:01
- 2024-10-30 04:01
- 2024-10-21 09:55
- 2024-10-16 08:44
- 2024-10-16 08:30
- 2024-10-15 20:30
- 2024-10-01 20:00
At What Oil Price Will Shale Drillers Stop Drilling?(Oilprice.com)
- 2024-09-12 16:52
- 2024-08-28 17:50
- 2024-08-27 12:49
- 2024-08-19 11:15
- 2024-08-16 07:39
- 2024-08-14 11:46
- 2024-08-07 07:48
Dow Jones Futures Fuel New Market Rally On Bank Of Japan; Nvidia Partner Super Micro Dives(Investor's Business Daily)
- 2024-08-06 22:53
Dow Jones Futures Rise On BoJ Signals After Stock Market Rally; Nvidia Partner Super Micro Dives(Investor's Business Daily)
Page 1 of 6
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.